Published: 29 February 2016
Committees
Agenda for the 165th meeting of the Medicines Adverse Reactions Committee to be held at The Rydges, 75 Featherston Street, Pipitea, Wellington on Thursday 10 MARCH 2016, at 9 am
1 |
Matters of Administration |
1.1 |
Welcome and apologies |
1.2 |
Minutes and recommendations of the 164th MARC meeting |
1.3 |
Declaration of potential conflicts of interest |
2 |
Medsafe Pharmacovigilance Activities |
2.1 |
Report on standing agenda items |
2.2 |
Medsafe pharmacovigilance activities |
2.3 |
Prescriber Update |
2.4 |
Quarterly summary of recent safety communications |
3 |
Pharmacovigilance Reports |
3.1 |
Matters referred to the MARC under section 36 of the Medicines Act 1981No items. |
3.2 |
Matters referred to the MARC by Medsafe |
3.2.1 |
Risk of pulmonary arterial hypertension with interferons alfa and beta |
3.2.2 |
Contraception with levonorgestrel subcutaneous implants (Jadelle) and weight-based efficacy |
3.2.3 |
Risk of adverse cardiovascular events in patients taking sulfonylureas |
4 |
Matters Arising from the NZ Pharmacovigilance Centre |
4.1 |
CARM Quarterly Report |
5 |
Other Business |
